Business Context and Reporting Period
This Form 6-K filing by Scully Royalty Ltd. (NYSE: SRL) covers the month of April 2021 and serves as a corporate update alongside the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2020. The Company's primary asset is a net revenues royalty interest in the Scully iron ore mine in Newfoundland and Labrador, Canada. The filing details a strategic pivot to focus exclusively on this royalty asset, classifying its Industrial and Merchant Banking segments as discontinued operations.
Key Financial Metrics
Based on the financial data provided for the period ended December 31, 2020 (in C$ '000s, except per share amounts):
- Total Assets: 509,125
- Total Liabilities: 147,581
- Shareholders' Equity: 361,544
- Consolidated Revenue: 59,432
- Income Before Income Taxes: 11,179
- Book Value Per Share: C$28.80 (US$22.62)
- Market Price Per Share: US$9.35 (as of April 27, 2021)
- Price-to-Book Ratio: 41.34%
Segment Performance (Dec 31, 2020):
- Royalty Segment: Revenue of 31,360; Pre-tax Income of 25,293.
- Industrial Segment: Revenue of 17,666; Pre-tax Loss of (1,229).
- Merchant Banking Segment: Revenue of 10,406; Pre-tax Income of 832.
The filing does not provide specific cash flow or debt maturity schedules for the current period, though it notes a minimum annual royalty payment of C$3.25 million.
Material Changes and Strategic Actions
The Company has announced several material changes to its corporate structure and capital allocation strategy:
- Discontinued Operations: The Industrial and Merchant Banking segments will be classified as discontinued operations in 2021 financial statements. Their assets and liabilities will be presented as "held for sale."
- Dividend Policy: The Board has approved a new cash dividend policy intended to maximize shareholder value. The first cash dividend is expected in the second half of 2021, subject to Board approval and financial results.
- Stock Dividends: To address share illiquidity and the discount between market price and book value, the Board approved two tax-free stock dividends: a 9% distribution on May 31, 2021, and an 8% distribution on November 30, 2021.
- Management Changes: Samuel Morrow has been appointed President and CEO, replacing Michael Smith, who will serve as Executive Chairman.
Outlook, Risks, and Contingencies
Outlook and Commentary: Management expects the Scully mine operator to continue ramping up production, with 2020 shipments totaling approximately 3 million tonnes. The Company anticipates that high-grade iron ore (65% Fe) will command a premium over standard grades. The focus is on simplifying the corporate structure to reflect the value of the core royalty asset.
Risks and Contingencies:
- Legal Dispute: A European Bank obtained a temporary order in the Cayman Islands restricting the sale of certain assets related to an alleged guarantee of approximately EUR 43 million. The Company disputes the validity of this guarantee and has filed a counterclaim. The appeal is expected to be heard in the second half of 2021. Management does not currently expect a material financial impact.
- Market Risks: Iron ore pricing is cyclical and dependent on global steel demand. Future dividends are not guaranteed and depend on the Company's financial position and the performance of the mine operator.
- Liquidity: The Company notes limited liquidity in its common shares, which restricts institutional ownership, prompting the stock dividend strategy.
Investor Verification Checklist
- Verify the approval status of the 9% and 8% stock dividends with the relevant stock exchanges.
- Monitor the timeline and outcome of the appeal regarding the European Bank dispute and the EUR 43 million guarantee claim.
- Review the audited Form 20-F for detailed cash flow statements and debt covenants not fully detailed in this summary.
- Confirm the timing and amount of the first cash dividend declaration in the second half of 2021.
- Track the production volumes and pricing premiums of the Scully mine operator to validate royalty revenue projections.